Biopharmaceutical
Section Gears Up for Statistics Workshop
Melvin Munsaka of Takeda Global Research & Development, Workshop Publicity Chair,
and Alan Menius of GlaxoSmithKline, Workshop Chair
F
or the 32nd consecutive year, Ball FDA and other governmental agencies costs, with preference given to students
State University in Muncie, will be invited to give presentations. who present posters. The best student
Indiana, will host the Midwest The clinical track, organized by poster, as judged by a committee, will
Biopharmaceutical Statistics Workshop Kimberly Crimin of Wyeth, will focus on receive the Charles Sampson Award,
(MBSW) May 18–20. Cosponsored by statistical considerations of critical path named in honor of a founder and guid-
the Biopharmaceutical Section of the initiatives and feature sessions on Bayesian ing force behind this successful series of
ASA, this year’s workshop sessions will methods in drug development, pharma- workshops. Students or faculty spon-
be held at the university’s alumni center. cometrics/modeling and simulation, and sors interested in applying for scholar-
The program and other information are quantitative safety assessment. The discov- ships should visit
www.mbswonline.com
available at
www.mbswonline.com. ery/preclinical track, organized by David for information.
MBSW was founded to meet the Stock of Bristol Myers Squibb, will look Every statistician in the pharmaceutical
needs of pharmaceutical industry stat- at accelerating drug discovery and charac- industry is encouraged to consider spend-
isticians in the Midwest. Although the terization. This track includes sessions on ing a few days at MBSW. Questions not
industry has changed and migrated to nonlinear mixed effect models, statistical answered on the web site may be addressed
both the East Coast and West Coast, modeling for toxicology, and drug discov- to Publicity Chair Melvin Munsaka at
the workshop has remained in Muncie ery. The post-marketing track, organized
mmunsaka@tgrd.com, 2009 Workshop
and welcomed attendees from across the by Patrick Ryan of GlaxoSmithKline, will Chair Alan Menius at alan.j.menius@gsk.
country and around the world. focus on analyses following approval and com, or Local Arrangements Chair Dale
The upcoming workshop will include sessions on post-approval data Umbach at
dumbach@bsu.edu. ■
begin with a half-day short course to mining opportunities, statistical issues
be taught by Michael O’Connell of for observational studies, and analyses for
TIBCO on Monday, May 18. The comparative effectiveness. The nonclinical
short course will discuss integrating track, organized by Stan Altan of Johnson
GILLINGS SCHOOL OF
graphics and statistics across pharma- & Johnson, will look at integrating statis-
GLOBAL PUBLIC HEALTH
ceutical research and development. tics and the pharmaceutical sciences in a
There will be two plenary speakers QBD world and include sessions on sta-
Biostatistics Workshops
on Monday afternoon: Scott Evans of tistical approaches to measurement uncer-
May 18-22, 2009
Harvard University on benefit/risk con- tainty in analytical chemistry, QBD, and
The Department of Biostatistics at the Univer-
siderations and Paul Stang of Johnson stability modeling.
sity of North Carolina at Chapel Hill is pleased
to announce a week of workshops May 18-22
& Johnson on the observational medi- Additional opportunities to meet
in Chapel Hill, NC, cosponsored by SAS Insti-
cal outcomes partnership. speakers and network will be afforded tute. A two-day Clinical Trials Workshop, led by
The 2009 workshop will have four during the Monday evening mixer and
Drs. Joseph Ibrahim and Anastasia Ivanova, will
parallel tracks, with sessions on Tuesday the Tuesday social hour, which precedes
cover adaptive designs from both frequentist and
and Wednesday. The four tracks cho- the banquet. The banquet speaker will be
Bayesian perspectives. New SAS software for
group sequential methods will be introduced.
sen for 2009 include a clinical track, a Stan Young of CGStat, whose talk is titled
discovery/preclinical track, a nonclini- “Everything Is Dangerous.” Two 1½-day genetics workshops will be led by
cal track, and a post-marketing track. Contributed posters are being accept-
Drs. Fred Wright, Wei Sun, and Fei Zou. The Ge-
Each track will have three sessions ed for the Tuesday poster session, to take
netic Association Analysis Workshop will intro-
(Tuesday morning, Tuesday afternoon, place during the lunch hour. Krishna
duce analysis methods for genotype and disease
associations, including specifi c genomic regions
and Wednesday morning). With each Padmanabhan of Wyeth is chair of the ses-
and whole-genome scans. The Microarray-based
session including three to five speakers sion and welcomes posters on any topic Gene Expression Analysis Workshop will intro-
and lasting more than two hours, speak- of interest to statisticians in the pharma-
duce methods for the analysis of high-throughput
ers will have time to discuss their top- ceutical industry. Poster abstracts must be
expression datasets. Prior experience in genetics
ics in detail and participants will have submitted by April 20, 2009. Details are
is not required.
ample opportunity to ask questions and provided at
www.mbswonline.com.
Practicing biostatisticians and other public health
explore other pertinent issues. Most ses- Students are especially encouraged researchers interested in attending one or more
sions will have multiple speakers from to participate in the MBSW activities.
workshops can register at
www.sph.unc.edu/oce
industry and at least one from aca- To help financially, limited scholarships
beginning January, 2009.
demia. In addition, speakers from the are available to students to offset travel
FEBRUARY 2009 AMSTAT NEWS 49
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84